Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
WD Quote, Financials, Valuation and Earnings
Last price:
$73.77
Seasonality move
:
0.69%
Day range:
$73.63 - $75.50
52-week range:
$64.48 - $118.19
Dividend yield:
3.58%
P/E ratio:
25.25x
P/S ratio:
2.14x
P/B ratio:
1.45x
Volume:
231.1K
Avg. volume:
292K
1-year change:
-31.38%
Market cap:
$2.5B
Revenue:
$1.1B
EPS (TTM):
$2.92
Analysts' Opinion
-
Consensus RatingWalker & Dunlop has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $105.00, Walker & Dunlop has an estimated upside of 35.65% from its current price of $73.72.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $95.00 representing 100% downside risk from its current price of $73.72.
Fair Value
-
According to the consensus of 4 analysts, Walker & Dunlop has 35.65% upside to fair value with a price target of $105.00 per share.
WD vs. S&P 500
-
Over the past 5 trading days, Walker & Dunlop has underperformed the S&P 500 by -3.69% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Walker & Dunlop does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Walker & Dunlop has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Walker & Dunlop reported revenues of $237.4M.
Earnings Growth
-
Walker & Dunlop earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Walker & Dunlop reported earnings per share of $0.08.
Enterprise value:
4.1B
EV / Invested capital:
--
Price / LTM sales:
2.14x
EV / EBIT:
38.70x
EV / Revenue:
3.58x
PEG ratio (5yr expected):
3.84x
EV / Free cash flow:
-20.11x
Price / Operating cash flow:
21.13x
Enterprise value / EBITDA:
11.86x
Gross Profit (TTM):
$505.1M
Return On Assets:
2.31%
Net Income Margin (TTM):
8.68%
Return On Equity:
5.68%
Return On Invested Capital:
2.97%
Operating Margin:
2.21%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $1.2B | $1B | $1.1B | $228.1M | $237.4M | |
| Gross Profit | $553.2M | $465.8M | $505.1M | $98.9M | $100.5M | |
| Operating Income | $196.1M | $116.8M | $105.7M | $13.7M | $5.2M | |
| EBITDA | $431.9M | $342.4M | $345M | $69.6M | $62.9M | |
| Diluted EPS | $5.04 | $2.74 | $2.92 | $0.35 | $0.08 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.8B | $1.5B | $1.7B | $1.2B | $1.7B | |
| Total Assets | $3.2B | $4.3B | $4.5B | $3.8B | $4.5B | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | $2B | $2.7B | $2.8B | $2.1B | $2.8B | |
| Total Equity | $1.2B | $1.6B | $1.7B | $1.7B | $1.7B | |
| Total Debt | $1.4B | $1.7B | $1.8B | $1.3B | $1.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $64.1M | $584.6M | -$190.1M | $38.4M | -$281.1M | |
| Cash From Investing | -$80.1M | $92.5M | -$52.5M | -$25.1M | -$39.4M | |
| Cash From Financing | $26.6M | -$631.2M | $191.5M | -$124.2M | $222M | |
| Free Cash Flow | $51.4M | $567.7M | -$203.5M | $35.2M | -$284.7M | |
WD
Sector
Market Cap
$2.5B
$633.8M
Price % of 52-Week High
62.37%
89.87%
Dividend Yield
3.58%
1.95%
Shareholder Yield
0.74%
4.06%
1-Year Price Total Return
-31.38%
7.88%
Beta (5-Year)
1.541
0.585
Dividend yield:
3.58%
Annualized payout:
$2.60
Payout ratio:
90.46%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$74.61
200-day SMA
Sell
Level
$89.75
Bollinger Bands (100)
Sell
Level
69.3 - 82.6
Chaikin Money Flow
Buy
Level
329.9K
20-day SMA
Buy
Level
$72.22
Relative Strength Index (RSI14)
Buy
Level
53.92
ADX Line
Buy
Level
24.41
Williams %R
Neutral
Level
-46.2206
50-day SMA
Buy
Level
$70.92
MACD (12, 26)
Buy
Level
20.66
25-day Aroon Oscillator
Buy
Level
68
On Balance Volume
Neutral
Level
690.1K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (1.9718)
Sell
CA Score
(Annual)
Level (-0.644)
Sell
Beneish M-Score
(Annual)
Level (-2.147)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-0.2234)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (3)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.
Stock Forecast FAQ
In the current month, WD has received 1 Buy ratings 3 Hold ratings, and 0 Sell ratings. The WD average analyst price target in the past 3 months is $105.00.
-
Where Will Walker & Dunlop Stock Be In 1 Year?
According to analysts, the consensus estimate is that Walker & Dunlop share price will rise to $105.00 per share over the next 12 months.
-
What Do Analysts Say About Walker & Dunlop?
Analysts are divided on their view about Walker & Dunlop share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Walker & Dunlop is a Sell and believe this share price will drop from its current level to $95.00.
-
What Is Walker & Dunlop's Price Target?
The price target for Walker & Dunlop over the next 1-year time period is forecast to be $105.00 according to 4 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is WD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Walker & Dunlop is a Hold. 3 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of WD?
You can purchase shares of Walker & Dunlop via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Walker & Dunlop shares.
-
What Is The Walker & Dunlop Share Price Today?
Walker & Dunlop was last trading at $73.77 per share. This represents the most recent stock quote for Walker & Dunlop. Yesterday, Walker & Dunlop closed at $73.72 per share.
-
How To Buy Walker & Dunlop Stock Online?
In order to purchase Walker & Dunlop stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
